Delivery Order SPE2DB20D9127-SPE2DB23FPPD2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $12,276.68 contract is for the supply of Rituxan 500 mg/50 ml vial, a pharmaceutical product used for medical treatment. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $38,347.10 to the woman-owned small business DMS Pharmaceutical Group Inc. based in Park Ridge, Illinois. The order is for the pharmaceutical product Rituxan 500 mg/50 ml vial and has a completion date of February 28, 2023. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $30,691.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4565781429 RITUXAN 500 MG/50 ML VIAL 50ML to DLA's Medical Supply Chain division. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999,...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $95,618.70 contract is for the delivery of Rituxan 500 mg/50 ml vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $33,760.87 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Rituxan 500 mg/50 ml vial, a pharmaceutical product used in medical care. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract #SPE2DB23D4600082013, which has a ceiling value of up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a Firm Fixed Price Delivery Order valued at $41,649.97, is for the supply of Rituxan 500 mg/50 ml vials to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,914.16 firm fixed-price contract is for the delivery of the biologic drug Rituxan 500 mg/50 ml vial. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,345.85 contract is for the supply of Rituxan 500 mg/50 ml vials. This delivery order is issued against DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery contract with DLA under the SPE2DB program, which enables the agency to order a broad range of pharmaceutical...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $5,965.88 to DMS Pharmaceutical Group Inc. for the supply of Rituxan 500 mg/50 mL vials on August 12, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, which is valued at approximately $500 million and extends through November 2026. The award carries no set-aside designation, allowing the woman-owned small business based in...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The $15,345.85 contract is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML, with a completion date of March 5, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, to provide a wide range of pharmaceutical products to military health...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB23FPPD2Delivery Order
The Defense Logistics Agency (DLA) awarded a $32,045.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4558921358 units of the pharmaceutical product Rituxan (500 mg/50 mL vial, 50 mL) to support the medical supply needs of military healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across various pharmaceutical product categories and medical domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.0k | 10/27/22 |